Acute liver injury is triggered by dysbiosis and microbial translocation involving gut-liver axis.
- 1Department of Pathology, Microbiology and Immunology, University of South Carolina School of Medicine, Columbia, SC, USA.
Abstract
Acute liver injury (ALI) is a severe clinical condition that can progress to chronic liver failure, cirrhosis, or hepatocellular carcinoma, yet therapeutic options remain limited. Here, we investigated how hepatotoxin-induced gut-liver dysbiosis drives hepatic inflammation through microbial crosstalk. Using three murine ALI models, we assessed liver injury, intestinal barrier integrity, microbial composition along the gut-liver axis, and immune activation. Each hepatotoxin recapitulated distinct features of human ALI and induced unique patterns of hepatic and intestinal injury, enabling the progressive translocation of live bacteria from the gut to the liver and bloodstream. ALI was consistently associated with depletion of commensal taxa (Lactobacillaceae, Ruminococcaceae, and Bifidobacteriaceae) and enrichment of opportunistic pathogens (Enterococcaceae, Clostridiaceae, Enterobacteriaceae, and Burkholderiaceae). Dysbiosis also involved reduced gut bacteriophages and the expansion of viral families, including Retroviridae and Herpesviridae, in the liver and blood. Transplantation of the fecal or liver microbiota from ALI mice into microbiota-depleted recipients reproduced liver injury, immune activation, and intestinal barrier disruption, demonstrating that dysbiotic microbial communities alone are sufficient to trigger hepatic inflammation. These communities activated Th₁/Th₁₇ associated pathways (NF-κB, IL-17, TGF-β, and antigen presentation networks) and expanded pro-inflammatory immune populations. A key advance of this study is the direct comparison of fecal- versus liver-derived microbiota, revealing distinct mechanistic roles for each in driving liver pathology. Across all models, hepatotoxin-induced intestinal barrier breakdown drives gut-liver dysbiosis, microbial translocation, and immune-mediated liver injury. These findings uncover a unifying mechanism by which microbial imbalance reprograms hepatic immunity and accelerates ALI progression.
Related
- Disrupted microbial queuosine biosynthesis contributes to dysbiosis of human inflammatory bowel disease
- Gut dysbiosis and microbial metabolites in atopic dermatitis: implications for immune regulation along gut-skin axis
- The gut-brain axis in Binge Eating Disorder: From microbial dysbiosis to vagal dysfunction and therapeutic intervention
- Microbial dysbiosis drives colorectal carcinogenesis via integrated inflammatory, metabolic, and biofilm pathways
- Cardiomyocyte-specific deletion of thioredoxin promotes myocardial injury, infarction and mitochondrial dysfunction: translocation of cytosolic thioredoxin into mitochondria rescue myocardial dysfunction by restoration of cardiac mitochondrial structure and function.
BibTeX
@article{halder2026acute,
title = {{Acute liver injury is triggered by dysbiosis and microbial translocation involving gut-liver axis.}},
author = {Urmi Halder and Hamida Hamida and Khadija Kakar and Xiaoming Yang and Yin Zhong and Mitzi Nagarkatti and Prakash Nagarkatti},
journal = {Gut microbes},
year = {2026},
month = oct,
doi = {10.1080/19490976.2026.2749977},
url = {https://europepmc.org/article/MED/42895196},
note = {CC BY},
}
RIS
TY - JOUR
TI - Acute liver injury is triggered by dysbiosis and microbial translocation involving gut-liver axis.
AU - Urmi Halder
AU - Hamida Hamida
AU - Khadija Kakar
AU - Xiaoming Yang
AU - Yin Zhong
AU - Mitzi Nagarkatti
AU - Prakash Nagarkatti
PY - 2026
DA - 2026/10/19
JO - Gut microbes
DO - 10.1080/19490976.2026.2749977
UR - https://europepmc.org/article/MED/42895196
AB - Acute liver injury (ALI) is a severe clinical condition that can progress to chronic liver failure, cirrhosis, or hepatocellular carcinoma, yet therapeutic options remain limited. Here, we investigated how hepatotoxin-induced gut-liver dysbiosis drives hepatic inflammation through microbial crosstalk. Using three murine ALI models, we assessed liver injury, intestinal barrier integrity, microbial composition along the gut-liver axis, and immune activation. Each hepatotoxin recapitulated distinct features of human ALI and induced unique patterns of hepatic and intestinal injury, enabling the progressive translocation of live bacteria from the gut to the liver and bloodstream. ALI was consistently associated with depletion of commensal taxa (Lactobacillaceae, Ruminococcaceae, and Bifidobacteriaceae) and enrichment of opportunistic pathogens (Enterococcaceae, Clostridiaceae, Enterobacteriaceae, and Burkholderiaceae). Dysbiosis also involved reduced gut bacteriophages and the expansion of viral families, including Retroviridae and Herpesviridae, in the liver and blood. Transplantation of the fecal or liver microbiota from ALI mice into microbiota-depleted recipients reproduced liver injury, immune activation, and intestinal barrier disruption, demonstrating that dysbiotic microbial communities alone are sufficient to trigger hepatic inflammation. These communities activated Th₁/Th₁₇ associated pathways (NF-κB, IL-17, TGF-β, and antigen presentation networks) and expanded pro-inflammatory immune populations. A key advance of this study is the direct comparison of fecal- versus liver-derived microbiota, revealing distinct mechanistic roles for each in driving liver pathology. Across all models, hepatotoxin-induced intestinal barrier breakdown drives gut-liver dysbiosis, microbial translocation, and immune-mediated liver injury. These findings uncover a unifying mechanism by which microbial imbalance reprograms hepatic immunity and accelerates ALI progression.
SN - 1949-0976
SN - 1949-0984
ER -